A Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage Non Small Cell Lung Cancer



Status:Completed
Conditions:Lung Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:4/2/2016
Start Date:November 2010
End Date:May 2014

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Outcome Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage NSCLC

For patients diagnosed with early (Stage I) non-small cell lung cancer, a lobe of lung is
usually removed at surgery to treat the cancer. For some patients, the removal of a lobe of
lung may leave too little lung behind for easy breathing. For some of these patients, it may
be possible to perform a smaller-scale surgery ("sub-lobar resection") and place a
radioactive implant behind to prevent the cancer from growing back. This study will see how
these patients do in terms of controlling their disease treated with a radioactive implant
called Cesium-131.


Inclusion Criteria:

1. Patients must have suspicious lung nodule for clinical stage I/recurrent non-small
cell Lung Cancer

2. Mass Tumor size < 7 cm

3. Patient must have a CT scan of the chest with upper abdomen within 90 days prior to
date of pre-registration.

4. Patient must have ECOG/Zubrod performance status 0,1, or 2.

Exclusion Criteria:

1. Patient has already received high dose radiation to the area

2. Cancerous nodule is very close to the esophagus or spinal cord, thereby increasing
the risk of radiation treatment

3. Pregnancy or unwillingness to practice a form of birth control (i.e. abstinence, oral
contraceptives, etc.)
We found this trial at
1
site
Weill-Cornell Medical College
New York, New York 10021
?
mi
from
New York, NY
Click here to add this to my saved trials